These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 9596408)

  • 21. [Rigid forms of Huntington's disease (study of a family with an anatomo-clinical case)].
    Delmas-Marsalet P; Bourgeois M; Vital C; Fontanges X
    Rev Neurol (Paris); 1968 Apr; 118(4):273-83. PubMed ID: 4235068
    [No Abstract]   [Full Text] [Related]  

  • 22. Huntington's disease - neuropathology.
    Vonsattel JP; Keller C; Cortes Ramirez EP
    Handb Clin Neurol; 2011; 100():83-100. PubMed ID: 21496571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. fMRI reveals altered auditory processing in manifest and premanifest Huntington's disease.
    Saft C; Schüttke A; Beste C; Andrich J; Heindel W; Pfleiderer B
    Neuropsychologia; 2008 Apr; 46(5):1279-89. PubMed ID: 18221758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Note on the pathology of the basal nucleus of Meynert in degenerative brain disorders.
    Tagliavini F; Pilleri G
    Schweiz Arch Neurol Neurochir Psychiatr; 1984; 135(2):277-80. PubMed ID: 6240766
    [No Abstract]   [Full Text] [Related]  

  • 25. Molecular genetics of Huntington's disease.
    Bobori C
    Adv Exp Med Biol; 2015; 822():59-65. PubMed ID: 25416977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response inhibition subprocesses and dopaminergic pathways: basal ganglia disease effects.
    Beste C; Willemssen R; Saft C; Falkenstein M
    Neuropsychologia; 2010 Jan; 48(2):366-73. PubMed ID: 19782093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two novel comments on the treatment of Huntington's disease.
    Gharibzadeh S; Sarbaz Y; Banaie M; Towhidkhah F
    J Neuropsychiatry Clin Neurosci; 2009; 21(1):98-9. PubMed ID: 19359460
    [No Abstract]   [Full Text] [Related]  

  • 28. [The basal ganglia. A clinical and physiopathological approach (author's transl)].
    Rondot P
    J Physiol (Paris); 1981 Apr; 77(1):119-30. PubMed ID: 6453222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopaminergic-peptidergic interactions in extrapyramidal disorders: a review of the clinical evidence.
    Gerstenbrand F; Poewe W
    Adv Neurol; 1987; 45():67-73. PubMed ID: 2881452
    [No Abstract]   [Full Text] [Related]  

  • 30. [Character and topography of neuropathologic changes in Hungington's chorea].
    Dymecki J; Ostrowska D
    Neurol Neurochir Pol; 1969; 3(3):355-64. PubMed ID: 4240866
    [No Abstract]   [Full Text] [Related]  

  • 31. The Neuropathology of Huntington's Disease.
    Waldvogel HJ; Kim EH; Tippett LJ; Vonsattel JP; Faull RL
    Curr Top Behav Neurosci; 2015; 22():33-80. PubMed ID: 25300927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of corticobasal degeneration and Huntington's disease: can Tau aggregates protect Huntingtin toxicity?
    Caparros-Lefebvre D; Kerdraon O; Devos D; Dhaenens CM; Blum D; Maurage CA; Delacourte A; Sablonnière B
    Mov Disord; 2009 May; 24(7):1089-90. PubMed ID: 19243029
    [No Abstract]   [Full Text] [Related]  

  • 33. Discriminative behavioral assessment unveils remarkable reactive astrocytosis and early molecular correlates in basal ganglia of 3-nitropropionic acid subchronic treated rats.
    Cirillo G; Maggio N; Bianco MR; Vollono C; Sellitti S; Papa M
    Neurochem Int; 2010 Jan; 56(1):152-60. PubMed ID: 19799953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bradykinesia is not a "systematic" feature of adult-onset Huntington's disease; implications for basal ganglia pathophysiology.
    Fenney A; Jog MS; Duval C
    Brain Res; 2008 Feb; 1193():67-75. PubMed ID: 18177845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Huntington's disease: molecular foundations and implications in the characterisation of the neuronal mechanisms responsible for linguistic processing].
    Benítez-Burraco A
    Rev Neurol; 2009 Jan 16-31; 48(2):75-84. PubMed ID: 19173205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A chorea kinship with rigid form].
    Neumayer E; Rett A
    Wien Z Nervenheilkd Grenzgeb; 1966; 23(1):74-85. PubMed ID: 4226898
    [No Abstract]   [Full Text] [Related]  

  • 37. Abnormal eye movements in three types of chorea.
    Attoni T; Beato R; Pinto S; Cardoso F
    Arq Neuropsiquiatr; 2016 Sep; 74(9):761-766. PubMed ID: 27706426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PET imaging of the basal ganglia.
    Laihinen A; Halsband U
    J Physiol Paris; 2006 Jun; 99(4-6):406-13. PubMed ID: 16723212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disorders of balance: a recent clinical neuro-otological study.
    Dix MR
    Proc R Soc Med; 1971 Aug; 64(8):857-60. PubMed ID: 4255004
    [No Abstract]   [Full Text] [Related]  

  • 40. On the neurolinguistic nature of language abnormalities in Huntington's disease.
    Wallesch CW; Fehrenbach RA
    J Neurol Neurosurg Psychiatry; 1988 Mar; 51(3):367-73. PubMed ID: 2452241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.